Items where Author is "Khamesipour, A."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 34.

Article

Jaafari, M. R. and Hatamipour, M. and Alavizadeh, S. H. and Abbasi, A. and Saberi, Z. and Rafati, S. and Taslimi, Y. and Mohammadi, A. M. and Khamesipour, A. (2019) Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis. International Journal for Parasitology: Drugs and Drug Resistance, 11. pp. 156-165.

Molkara, S. and Poursoltani, E. and Stahl, K. W. and Maleki, M. and Khamesipour, A. and Bogdan, C. and Salehi, M. and Goyonlo, V. M. (2019) Salvage therapy with Sodium chlorosum (formerly DAC N-055) for cases of refractory lupoid cutaneous leishmaniasis: Results from a compassionate use study with 0.09 Sodium chlorosum in amphiphilic basic cream. BMC Infectious Diseases, 19 (1).

Jafari, I. and Heravi Shargh, V. and Shahryari, M. and Abbasi, A. and Jaafari, M. R. and Khamesipour, A. and Badiee, A. (2018) Cationic liposomes formulated with a novel whole Leishmania lysate (WLL) as a vaccine for leishmaniasis in murine model. Immunobiology, 223 (6-7). pp. 493-500.

Olliaro, P. and Grogl, M. and Boni, M. and Carvalho, E. M. and Chebli, H. and Cisse, M. and Diro, E. and Fernandes Cota, G. and Erber, A. C. and Gadisa, E. and Handjani, F. and Khamesipour, A. and Llanos-Cuentas, A. and López Carvajal, L. and Grout, L. and Lmimouni, B. E. and Mokni, M. and Nahzat, M. S. and Ben Salah, A. and Ozbel, Y. and Pascale, J. M. and Rizzo Molina, N. and Rode, J. and Romero, G. and Ruiz-Postigo, J. A. and Gore Saravia, N. and Soto, J. and Uzun, S. and Mashayekhi, V. and Vélez, I. D. and Vogt, F. and Zerpa, O. and Arana, B. (2018) Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation. PLoS Neglected Tropical Diseases, 12 (1).

Emami, T. and Rezayat, S. M. and Khamesipour, A. and Madani, R. and Habibi, G. and Hojatizade, M. and Jaafari, M. R. (2018) The role of MPL and imiquimod adjuvants in enhancement of immune response and protection in BALB/c mice immunized with soluble Leishmania antigen (SLA) encapsulated in nanoliposome. Artificial Cells, Nanomedicine and Biotechnology, 46 (sup2). pp. 324-333.

Naseri, H. and Eskandari, F. and Jaafari, M. R. and Khamesipour, A. and Abbasi, A. and Badiee, A. (2017) PEGylation of cationic liposomes encapsulating soluble Leishmania antigens reduces the adjuvant efficacy of liposomes in murine model. Parasite Immunology, 39 (11).

Tafaghodi, M. and Eskandari, M. and Khamesipour, A. and Jaafaric, M. R. (2016) Immunization against cutaneous Leishmaniasis by alginate microspheres loaded with autoclaved Leishmania major (ALM) and Quillaja saponins. Iranian Journal of Pharmaceutical Research, 15 (2). pp. 573-581.

Mobasheri, M. and Attar, H. and Sorkhabadi, S. M. R. and Khamesipour, A. and Jaafari, M. R. (2016) Solubilization behavior of polyene antibiotics in nanomicellar system: Insights from molecular dynamics simulation of the amphotericin B and Nystatin interactions with polysorbate 80. Molecules, 21 (1).

Mehravaran, A. and Jaafari, M. R. and Jalali, S. A. and Khamesipour, A. and Ranjbar, R. and Hojatizade, M. and Badiee, A. (2016) The role of ISCOMATRIX bilayer composition to induce a cell mediated immunity and protection against leishmaniasis in BALB/c mice. Iranian Journal of Basic Medical Sciences, 19 (2). pp. 178-186.

Mehravaran, A. and Jaafari, M. R. and Jalali, S. A. and Khamesipour, A. and Tafaghodi, M. and Hojatizade, M. and Abbasi, A. and Badiee, A. (2015) Cationic immune stimulating complexes containing soluble leishmania antigens: Preparation, characterization and in vivo immune response evaluation. Iranian Journal of Immunology, 12 (4). pp. 274-287.

Jabini, R. and Jaafari, M. R. and Vahdati Hasani, F. and Ghazizadeh, F. and Khamesipour, A. and Karimi, G. (2015) Effects of combined therapy with silymarin and glucantime on Leishmaniasis induced by Leishmania major in BALB/c mice. Drug Research, 65 (3). pp. 119-124.

Moosavian Kalat, S. A. and Khamesipour, A. and Bavarsad, N. and Fallah, M. and Khashyarmanesha, Z. and Feizi, E. and Neghabi, K. and Abbasi, A. and Jaafari, M. R. (2014) Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB/c mice. Experimental Parasitology, 143 (1). pp. 5-10.

Kazemi-Rad, E. and Mohebali, M. and Erfan, M. B. K. and Saffari, M. and Raoofian, R. and Hajjaran, H. and Hadighi, R. and Khamesipour, A. and Rezaie, S. and Abedkhojasteh, H. and Heidari, M. (2013) Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach. Experimental Parasitology, 135 (2). pp. 344-349.

Heravi Shargh, V. and Jaafari, M. R. and Khamesipour, A. and Jalali, S. A. and Firouzmand, H. and Abbasi, A. and Badiee, A. (2012) Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis. Parasitology Research, 111 (1). pp. 105-114.

Bavarsad, N. and Fazly Bazzaz, B. S. and Khamesipour, A. and Jaafari, M. R. (2012) Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice. Acta Tropica, 124 (1). pp. 33-41.

Golali, E. and Jaafari, M. R. and Khamesipour, A. and Abbasi, A. and Saberi, Z. and Badiee, A. (2012) Comparison of in vivo adjuvanticity of liposomal PO CpG odn with liposomal PS CpG ODN: Soluble leishmania antigens as a model. Iranian Journal of Basic Medical Sciences, 15 (5). pp. 1032-1045.

Shargh, V. H. and Jaafari, M. R. and Khamesipour, A. and Jaafari, I. and Jalali, S. A. and Abbasi, A. and Badiee, A. (2012) Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis. Vaccine, 30 (26). pp. 3957-3964.

Shargh, V. H. and Jaafari, M. R. and Khamesipour, A. and Jaafari, I. and Jalali, S. A. and Abbasi, A. and Badiee, A. (2012) Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis. Vaccine, 30 (26). pp. 3957-3964.

Shargh, V. H. and Jaafari, M. R. and Khamesipour, A. and Jaafari, I. and Jalali, S. A. and Abbasi, A. and Badiee, A. (2012) Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis. Vaccine, 30 (26). pp. 3957-3964.

Khamesipour, A. and Abbasi, A. and Firooz, A. and Amin Mohammadi, A. M. and Eskandari, S. E. and Jaafari, M. R. (2012) Treatment of cutaneous lesion of 20 years' duration caused by leishmanization. Indian Journal of Dermatology, 57 (2). pp. 123-125.

Badiee, A. and Khamesipour, A. and Samiei, A. and Soroush, D. and Shargh, V. H. and Kheiri, M. T. and Barkhordari, F. and Robert Mc Master, W. and Mahboudi, F. and Jaafari, M. R. (2012) The role of liposome size on the type of immune response induced in BALB/c mice against leishmaniasis: rgp63 as a model antigen. Experimental parasitology, 132 (4). pp. 403-409.

Alavizadeh, S. H. and Badiee, A. and Khamesipour, A. and Jalali, S. A. and Firouzmand, H. and Abbasi, A. and Jaafari, M. R. (2012) The role of liposome-protamine-DNA nanoparticles containing CpG oligodeoxynucleotides in the course of infection induced by Leishmania major in BALB/c mice. Experimental Parasitology, 132 (3). pp. 313-319.

Tafaghodi, M. and Eskandari, M. and Khamesipour, A. and Jaafari, M. R. (2011) Alginate microspheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN induced partial protection and enhanced immune response against murine model of leishmaniasis. Experimental Parasitology, 129 (2). pp. 107-114.

Tafaghodi, M. and Eskandari, M. and Khamesipour, A. and Jaafari, M. R. (2011) Alginate microspheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN induced partial protection and enhanced immune response against murine model of leishmaniasis. Experimental Parasitology, 129 (2). pp. 107-114.

Tafaghodi, M. and Eskandari, M. and Khamesipour, A. and Jaafari, M. R. (2011) Alginate microspheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN induced partial protection and enhanced immune response against murine model of leishmaniasis. Experimental Parasitology, 129 (2). pp. 107-114.

Tafaghodi, M. and Khamesipour, A. and Jaafari, M. R. (2011) Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN. Parasitology Research, 108 (5). pp. 1265-1273.

Tafaghodi, M. and Khamesipour, A. and Jaafari, M. R. (2011) Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN. Parasitology Research, 108 (5). pp. 1265-1273.

Tafaghodi, M. and Khamesipour, A. and Jaafari, M. R. (2011) Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN. Parasitology Research, 108 (5). pp. 1265-1273.

Tafaghodi, M. and Eskandari, M. and Kharazizadeh, M. and Khamesipour, A. and Jaafari, M. R. (2010) Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins. Tropical Biomedicine, 27 (3). pp. 639-650.

Tafaghodi, M. and Eskandari, M. and Kharazizadeh, M. and Khamesipour, A. and Jaafari, M. R. (2010) Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins. Tropical Biomedicine, 27 (3). pp. 639-650.

Tafaghodi, M. and Eskandari, M. and Kharazizadeh, M. and Khamesipour, A. and Jaafari, M. R. (2010) Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins. Tropical Biomedicine, 27 (3). pp. 639-650.

Jaafari, M. R. and Bavarsad, N. and Bazzaz, B. S. F. and Samiei, A. and Soroush, D. and Ghorbani, S. and Heravi, M. M. L. and Khamesipour, A. (2009) Effect of topical liposomes containing paromomycin sulfate in the course of Leishmania major infection in susceptible BALB/c mice. Antimicrobial Agents and Chemotherapy, 53 (6). pp. 2259-2265.

Badiee, A. and Jaafari, M. R. and Samiei, A. and Soroush, D. and Khamesipour, A. (2008) Coencapsulation of CpG oligodeoxynucleotides with recombinant Leishmania major stress-inducible protein 1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB/c mice. Clinical and Vaccine Immunology, 15 (4). pp. 668-674.

Firooz, A. and Khamesipour, A. and Ghoorchi, M. H. and Nassiri-Kashani, M. and Eskandari, S. E. and Khatami, A. and Hooshmand, B. and Gorouhi, F. and Rashighi-Firoozabadi, M. and Dowlati, Y. (2006) Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: A randomized assessor-blind controlled trial. Archives of Dermatology, 142 (12). pp. 1575-1579.

This list was generated on Sun May 16 20:50:47 2021 EDT.